Actionable news
All posts from Actionable news
Actionable news in VRTX: Vertex Pharmaceuticals Incorporated,

Vertex Pharmaceuticals (VRTX) Jeffrey M. Leiden on Q3 2015 Results - Earnings Call Transcript


Good afternoon ladies and gentlemen. My name is Candice. Vertex's Third Quarter 2015 Financial Results Call is about to begin.

Michael Partridge - Vice President-Investor Relations

Good evening everyone. This is Michael Partridge, head of investor relations for Vertex Pharmaceuticals. Welcome to our third quarter 2015 financial results conference call. At this time all participants are in a listen-only mode. Later we will open the lines for questions.

As a reminder, this conference call is being recorded and a replay will be available following the conclusion of tonight's call on our website. Joining me on tonight's call are Dr. Jeff Leiden, Chairman and CEO; Stuart Arbuckle, Chief Commercial Officer; Ian Smith, Chief Financial Officer; and Dr. David Altshuler, our Chief Scientific Officer. Doctor Jeff Chodakewtiz, Chief Medical Officer will also be available for Q&A.

Our agenda tonight is as follows. Jeff will review the progress with our cystic fibrosis medicines. Stuart will review the third-quarter sales performance of our marketed products. Ian will review the third...